Balancing the benefits and costs of new therapies for myelodysplastic syndromes

Published on

Dr Valeria Santini, Associate Professor of Hematology at the University of Florence, Florence, Italy, who presented new data on treatments for myelodysplastic syndromes (MDS) at the 20th Congress of the European Hematology Association (EHA), considers the issue of access to these new treatments in Europe.

View more programs featuring

Page last updated on January 26, 2016